Milacemide
Chemical compound / From Wikipedia, the free encyclopedia
Milacemide (INN)[2] is an MAO-B inhibitor and glycine prodrug.[3] It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease.[4] Early clinical trials did not show positive results however,[3] and the drug is now abandoned and it is sold as a nonprescription drug or supplement. While milacemide is not an amino-acid, it acts similarly to glycine in the brain.[5]
Quick Facts Names, Identifiers ...
Names | |
---|---|
IUPAC name
N2-Pentylglycinamide | |
Systematic IUPAC name
2-(Pentylamino)acetamide[1] | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
MeSH | milacemide |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C7H16N2O | |
Molar mass | 144.218 g·mol−1 |
log P | 0.754 |
Related compounds | |
Related compounds |
Tricine |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Close